Saturday, July 11, 2026

pharma · Acne Vulgaris

Cutia Therapeutics (Shanghai)

Cutia Therapeutics (Shanghai) clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
1
Patents
0
Intelligence · Clinical Programs

Cutia Therapeutics (Shanghai) projects

1 ClinicalTrials.gov programs sponsored by Cutia Therapeutics (Shanghai).

Cutia Therapeutics (Shanghai) has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. FMX101

    Cutia Therapeutics (Shanghai) Co., Ltd

    Acne Vulgaris

    phase 3 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Cutia Therapeutics (Shanghai) have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.